IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 225 filers reported holding IVERIC BIO INC in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,933,017 | +53.8% | 99,975 | -4.9% | 0.01% | +37.5% |
| Q1 2023 | $2,557,326 | +4.5% | 105,110 | -8.0% | 0.01% | 0.0% |
| Q4 2022 | $2,447,334 | +67.2% | 114,308 | +40.1% | 0.01% | +60.0% |
| Q3 2022 | $1,464,000 | +77.5% | 81,619 | -4.8% | 0.01% | +150.0% |
| Q2 2022 | $825,000 | -68.0% | 85,759 | -44.0% | 0.00% | -60.0% |
| Q1 2022 | $2,577,000 | -11.9% | 153,100 | -12.5% | 0.01% | -16.7% |
| Q4 2021 | $2,924,000 | +37.7% | 174,900 | +33.8% | 0.01% | +50.0% |
| Q3 2021 | $2,123,000 | +197.3% | 130,700 | +15.5% | 0.00% | +300.0% |
| Q2 2021 | $714,000 | +2.0% | 113,200 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $700,000 | -10.5% | 113,200 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $782,000 | +90.3% | 113,200 | +55.3% | 0.00% | +100.0% |
| Q3 2020 | $411,000 | – | 72,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |